(Q40842144)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8364001%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

review article

1 reference

title

Pharmacological control of hypertriglyceridemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8364001%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8364001%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

author name string

R Paoletti

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8364001%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

publication date

1 June 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8364001%20AND%20SRC:MED&resulttype=core&format=json

Cardiovascular Drugs and Therapy

30 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8364001%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8364001%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8364001%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

page(s)

297-302

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8364001%20AND%20SRC:MED&resulttype=core&format=json

HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study

30 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF00880152

Combination drug therapy for familial combined hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00880152

Cardiovascular Effects of n-3 Fatty Acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00880152

Hypertriglyceridemia and regulation of fibrinolytic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00880152

Bezafibrate lowers plasma lipids, fibrinogen and platelet aggregability in hypertriglyceridaemia.

21 January 2018

1 reference

12 December 2020

Effects of dietary fish oil supplementation on platelet aggregability and platelet membrane fluidity in normolipemic subjects with and without high plasma Lp(a) concentrations

1 reference

12 December 2020

Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment

1 reference

12 December 2020

Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery disease

1 reference

12 December 2020

Interrelationships between plasma levels of plasminogen activator inhibitor, tissue plasminogen activator, lipoprotein (a), and established cardiovascular risk factors in a north Swedish population

1 reference

12 December 2020

Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid

1 reference

12 December 2020

Dietary supplementation with low-dose fish oils lowers fibrinogen levels: a randomized, double-blind controlled study

1 reference

12 December 2020

Cholesterol accumulation in J774 macrophages induced by triglyceride-rich lipoproteins. Comparison of very low density lipoprotein from subjects with type III, IV, and V hyperlipoproteinemias.

1 reference

12 December 2020

Association between coagulation factors VII and X with triglyceride rich lipoproteins

1 reference

12 December 2020

High density lipoprotein cholesterol and triglycerides as markers of angiographically assessed coronary artery disease

1 reference

12 December 2020

Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

1 reference

12 December 2020

Lipoprotein changes and increased affinity of LDL for their receptors after acipimox treatment in hypertriglyceridemia

1 reference

12 December 2020

Relative increase in apolipoprotein CII content of VLDL and chylomicrons in a case with massive type V hyperlipoproteinaemia by nicotinic acid treatment

1 reference

12 December 2020

Plasminogen activator and plasminogen activator inhibitor activities in men with coronary artery disease

1 reference

12 December 2020

Inhibition of lipolysis by nicotinic acid and by acipimox

1 reference

12 December 2020

Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH)

1 reference

12 December 2020

Effects of fibrates on serum lipids and atherosclerosis

1 reference

12 December 2020

A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators

1 reference

12 December 2020

Treatment of hypertriglyceridemia with metformin. Effectiveness and analỳsis of results

1 reference

12 December 2020

Metformin decreases the high plasminogen activator inhibition capacity, plasma insulin and triglyceride levels in non-diabetic obese subjects.

1 reference

12 December 2020

High prevalence of hypertriglyceridaemia and apolipoprotein abnormalities in coronary artery disease

1 reference

12 December 2020

Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review.

1 reference

12 December 2020

NIH Consensus conference. Triglyceride, high-density lipoprotein, and coronary heart disease. NIH Consensus Development Panel on Triglyceride, High-Density Lipoprotein, and Coronary Heart Disease

1 reference

12 December 2020

Tolerability of fibric acids. Comparative data and biochemical bases.

1 reference

12 December 2020

Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Münster study

1 reference

12 December 2020

Hypercoagulability and factor VII in hypertriglyceridemia

1 reference

12 December 2020

Gemfibrozil alone and in combination with lovastatin for treatment of hypertriglyceridemia in NIDDM

1 reference

12 December 2020

Influence of plasma triglycerides on lipoprotein patterns in normal subjects and in patients with coronary artery disease

1 reference

12 December 2020

Olive oil, corn oil, and n-3 fatty acids differently affect lipids, lipoproteins, platelets, and superoxide formation in type II hypercholesterolemia

1 reference

12 December 2020

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

1 reference

12 December 2020

Effect of alteration in triglyceride levels on factor VII-phospholipid complexes in plasma

1 reference

12 December 2020

Abnormal regulation of LDL receptor activity and abnormal cellular metabolism of hypertriglyceridaemic low density lipoprotein: normalization with bezafibrate therapy

1 reference

12 December 2020

The induction of liver peroxisomal proliferation by beta,beta'-methyl-substituted hexadecanedioic acid (MEDICA 16).

1 reference

12 December 2020

Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00880152

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8364001%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

1 reference